NEUP
Neuphoria Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Neuphoria Therapeutics Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
0.00%
NEUP weight · VTI
Expected move
No implied move.
—
No other changes.
No other changes.
Neuphoria Therapeutics Inc.'s mission is to develop impactful treatments for neuropsychiatric disorders, bringing new hope and tangible improvements to patients’ lives. They are headquartered in Burlington, MA.
Neuphoria Therapeutics Inc.'s mission is to develop impactful treatments for neuropsychiatric disorders, bringing new hope and tangible improvements to patients’ lives. They are headquartered in Burlington, MA.
Annual filing, covered
10-K parsed · Sep 18 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Sep 18 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Neuphoria Therapeutics Inc..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Neuphoria Therapeutics Inc..
Linked news
News| Manager | Value | % base | |
|---|---|---|---|
| Lynx1 | $3.8M | 44.49% | 0.00% |
| AdvisorShares | $1.1M | 12.85% | +62.78% |
| Vanguardindex-like | $758,143 | 8.82% | +76.10% |
| Shay Capital | $680,942 | 7.92% | +3.19% |
| Balyasny | $621,536 | 7.23% | +0.03% |
| Manager | Value | % base | |
|---|---|---|---|
| Lynx1 | $3.8M | 44.49% | 0.00% |
| AdvisorShares | $1.1M | 12.85% | +62.78% |
| Vanguardindex-like | $758,143 | 8.82% | +76.10% |
| Shay Capital | $680,942 | 7.92% | +3.19% |
| Balyasny | $621,536 | 7.23% | +0.03% |
+14.23%
shares held · 10 largest managers
Bull3
Bear1
Neuphoria Therapeutics Inc.
3.00
+0.01 · +0.33%